Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
27-Feb-16 The CFDA has said it would prioritize the approval of drugs with clear clinical value, including those that use advanced technology or innovative methods. It added that certain categories of drugs would get priority, including those for children and the elderly, rare diseases, AIDS, malignant tumors and viral hepatitis. [image: Aly Song / Reuters]Read More
26-Feb-16 Cognizant has announced the development of a new digital healthcare platform, Cognizant Health TranZform™. Developed with technology from Orion Health, this new digital platform will help consumers make more informed decisions about the cost and quality of their care, while simultaneously enabling healthcare providers and payers to drive greater levels of consumer engagement and operational efficiency. [image: Cognizant]Read More
26-Feb-16 Singapore based startup RingMD, that enables patients and medical professionals of their choice to be easily connected for online video consultations, has signed an MOU with Digital India to reach patients in rural India. [image: RingMD]Read More
26-Feb-16 Indian healthcare is growing at 17% and is expected to be worth USD280 bn by 2020. Even so, nearly one million people die every year due to inadequate facilities and almost 700 mn have no access to specialist care. The Government has planned a 'complete transformation' of the sector. It now needs to act on its plans and allocate more money. [image: Reuters]Read More
25-Feb-16 Carestream Health has struck a deal with Alibaba Health Information Technologies to create an Internet-based medical-image sharing service in China. The system is to wed Carestream’s image sharing technology and Alibaba Health’s online platform. “This new service... facilitates patients’ accessibility to medical consultation by eliminating the need to travel to health care facilities" Alibaba Health vice president Ni Jianwen said. [image: Business Wire]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Get in touch to discuss your growth markets research and advisory needs: